LivaMac-450: Specialized Liver & Bile Duct SupportLivaMac-450 by MK Healthcare is a specialized pharmaceutical formulation containing Ursodeoxycholic Acid ($450\text{ mg}$), designed for targeted liver health and gallstone management. As a naturally occurring bile acid, UDCA is essential for regulating cholesterol absorption and dissolving certain types of gallstones. It is the key therapeutic agent for patients needing to improve bile flow and protect liver cells from the damage caused by retained bile.Effective Management of Cholestasis: LivaMac-450 is primarily indicated for treating Primary Biliary Cholangitis (PBC) and other forms of intrahepatic cholestasis (impaired bile flow within the liver). The $450\text{ mg}$ strength works by increasing the hydrophilicity of the bile acid pool, reducing the toxicity of existing bile acids, and protecting the delicate membranes of liver cells (hepatocytes). This essential hepatoprotective action helps normalize elevated liver enzymes and improves overall liver function.Non-Surgical Gallstone Dissolution: For specific patients, LivaMac-450 offers a non-surgical option for the dissolution of small, non-calcified cholesterol gallstones. The Ursodeoxycholic Acid works to decrease the cholesterol saturation of bile, gradually facilitating the breakdown and elimination of the stones. This makes it a crucial medication for those managing cholelithiasis and seeking an alternative to invasive procedures.Premium Quality and Reliable Therapy: Manufactured by MK Healthcare under stringent quality standards, LivaMac-450 provides a consistent and reliable dose of $450\text{ mg}$ UDCA in a convenient tablet form. For physicians and patients focused on the precise management of chronic liver diseases and bile-related conditions, LivaMac-450 represents a trusted choice for supporting long-term health, detoxification, and the maintenance of a healthy biliary system.
